Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Summary

This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care visits along with administration of ICG dye and imaging during surgery. Participation in this study will last approximately 6 weeks.

Timeline

Start

2026-05-04

Primary completion

2028-04-07

Completion

2029-04-07

Drugs

Indications